Latest Blogs

Aug 11, 2022
Dr. Tara Rajendran celebrates the legacy and mentorship of Dr. Karen Jean Marcus upon her retirement after 33-year career at the Dana-Farber Cancer Institute.
Jul 27, 2022
Dr. Anna M Laucis discusses the landscape and future opportunities for narrative medicine, along with her own explorations in original artwork and poetry.
Jul 21, 2022
It feels great to celebrate 17 consecutive years of organizing the Best of ASCO Lebanon meeting, including a well-received event featuring expert faculty in 2022.
Jul 20, 2022
The weeks following the ASCO Annual Meeting always feel like a bit of a reset, as we emerge energized from connecting with friends and colleagues.
Subscribe to this column

Gilberto Lopes, MD, FASCO, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, is associate director for global oncology and interim chief for the Division of Medical Oncology at the Sylvester Comprehensive Cancer Center and professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor-in-chief for JCO Global Oncology, among other volunteer roles at ASCO. Follow him on Twitter @GlopesMd.

Disclosure.

May 23, 2016
This is the story of how, like Mr. Smith in Washington, the medical community in Brazil gathered to speak truth to power about the lack of evidence for phosphoethanolamine as a cancer treatment.
Apr 05, 2016
This is the story of how a populist Congress approved the medication that wasn't, and oncologists in the country are waiting to see if an enfeebled president will be able to veto the bill.
Feb 24, 2016
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
Feb 03, 2016
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
Jan 21, 2016
Price discrimination is an inequitable-sounding, but important, concept of charging different prices for the same product or service in different markets or segments of a market, usually based on consumers’ ability to pay.
Dec 09, 2015
In 2012, in an attempt to answer the call to prioritize interventions, my colleagues and I, with support from the Asian Oncology Summit and Lancet Oncology, discussed and agreed upon a resource-stratified consensus on the management of colon cancer.

Pages